E-LIB Suche - Ergebnisse für: Bondarenko, Igor

1

Efbemalenograstim alfa not inferior to pegfilgrastim in pro..:

Glaspy, John ; Bondarenko, Igor ; Krasnozhon, Dmitrii...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776461/. , 2024

Link: http://www.ncbi.nlm.nih...

2

Efbemalenograstim alfa not inferior to pegfilgrastim in pro..:

Bondarenko, Igor ; Krasnozhon, Dmitrii ; Rutty, Dean...
qt56h767sg. , 2024

Link: https://escholarship.org..

3

Far-reaching impact of the Russian invasion of Ukraine on g..:

Bondarenko, Igor ; Agarwal, Ajay ; Van Hemelrijck, Mieke...
Bondarenko , I , Agarwal , A , Van Hemelrijck , M , Lawler , M , Zubaryev , M & Sullivan , R 2023 , ' Far-reaching impact of the Russian invasion of Ukraine on global cancer research ' , European Journal of Cancer , vol. 183 , pp. 95-97 . https://doi.org/10.1016/j.ejca.2023.01.020. , 2023

Link: https://pure.qub.ac.uk/e..

4

Patient-reported outcomes with cemiplimab monotherapy for f..:

Gumus, Mahmut ; Chen, Chieh-, I ; Ivanescu, Cristina...
Cancer. , 2023

Link: https://doi.org/10.1002/..

5

Efficacy and safety of the proposed bevacizumab biosimilar ..:

Likun Chen ; Jose David Gomez Rangel ; Timucin Cil...
https://doi.org/10.1002/cam4.6664. , 2023

Link: https://doi.org/10.1002/..

6

Efbemalenograstim alfa, an Fc fusion protein, long-acting g..:

Bondarenko, Igor ; Burdaeva, Olga ; Chen, Jianmin...
qt0389k3xv. , 2023

Link: https://escholarship.org..

7

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy a..:

de Castro, Gilberto ; Kudaba, Iveta ; Wu, Yi-Long...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082298/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Efbemalenograstim alfa, an Fc fusion protein, long-acting g..:

Glaspy, John ; Bondarenko, Igor ; Burdaeva, Olga...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725375/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Overall Survival with Palbociclib and Fulvestrant in Women ..:

Cristofanilli, Massimo ; Rugo, Hope S ; Im, Seock-Ah...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662922/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Long-Term Safety and Effectiveness of PF-05280014 (a Trastu..:

Li, Rubi K ; Tokunaga, Eriko ; Adamchuk, Hryhoriy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847243/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Overall Survival With Palbociclib And Fulvestrant in Women ..:

Cristofanilli, Massimo ; Rugo, Hope S ; Im, Seock-Ah...
qt4nz4j29z. , 2022

Link: https://escholarship.org..

12

Patient‐reported outcomes with cemiplimab monotherapy for f..:

Gümüş, Mahmut ; Chen, Chieh‐I ; Ivanescu, Cristina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092585/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Evaluating Alternative Ramucirumab Doses as a Single Agent ..:

Shah, Manish A ; Udrea, Anghel Adrian ; Bondarenko, Igor...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909008/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Overall Survival with Palbociclib and Fulvestrant in Women ..:

Cristofanilli, Massimo ; Rugo, Hope S ; Im, Seock-Ah...
Clinical Cancer Research, Vol.28 No.16, pp.3433-3422. , 2022

Link: https://hdl.handle.net/1..

15

Patient-reported outcomes (PROs) of cemiplimab vs chemother..:

Sezer, A ; Kılıçkap, Saadettin ; Gümüş, M...
10.1016/j.annonc.2022.07.1306. , 2022

Link: https://hdl.handle.net/2..